维普中文期刊产品整合服务
18篇 您的检索式:作者名="Dermawan"
    题名 作者 年代 出处 被引量
1Differential impairment of regula-tory T cells rather than effector T cells by paclitaxel- based chemo-therapy 显示文摘Zhang L Dermawan K Jin M 2008Clin Immunol2008,129,2:1
2In traffic jam IVC-RVC system for ITS using bluetooth 显示文摘Akihika Sugiura Candra Dermawan 2005IEEE Transactions on Intelligent Transportation System2005,6,3:1
3Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells? 显示文摘Zhang L Dermawan KT Jin ML el al 2008Med Hypotheses2008,198,5:1
4Can large scale land acquisition for agro-development in Indonesia be managed sustainably? 显示文摘Krystof Obidzinskia Ikuko Takahashi Ahmad Dermawan 2013Land Use Policy2013,30,:1
5Differential impair- ment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy显示文摘Zhang L Dermawan K Jin M 2008Clin Immunol2008,129,2:1
6pH-conductivity hybrid gradient cation-exchange chromatography for process-scale monoclonal antibody purification 显示文摘Zhou JX Dermawan S Solamo F 2007J Chromatogr A2007,1175,1:1
7Quinacrine overcomes resistance to erlotinib by inhibiting FACT,NF-κB,and cell-cycle progression in non-small cell lung cancer显示文摘Dermawan JK Gurova K Pink J 2014Mol Cancer Ther2014,13,9:1
8Highly syn-ergistic effect of sequential treatment with epigenetic and antican-cer drugs to overcome drug resistance in breast cancer cells is me-diated via activation of p21 gene expression leading to G2/M cyclearrest显示文摘Vijayaraghavalu S Dermawan JK Cheriyath V 2013Mol Pharm2013,10,1:1
925例CD34阴性孤立性纤维性肿瘤临床病理研究并与CD34阳性者比较显示文摘CD34阴性孤立性纤维性肿瘤(SFT)少见,为此作者回顾性研究了克利夫兰诊所病理系2013—2020年经免疫组化和/或二代测序(NGS)证实的携有STAT6基因融合的SFT病例,分析了相关临床病理参数如组织学特征、核分裂数、非典型及肿瘤坏死,发现244例SFT中25例(10%)免疫组化缺乏CD34表达;与CD34阳性SFT(大多细胞形态温和,呈梭形)相比,CD34-SFT更常见于头颈部(32%vs. 24%,P=0.02)而非胸腔。Dermawan JK Rubin BP Kilpatrick SE 方三高(译) 易祥华(校) 2022诊断病理学杂志2022,29,5:1
10Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy 显示文摘Zhang L Dermawan K Jin M 2008Clin Immunol2008,129,2:1
11Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy 显示文摘Zhang L Dermawan K Jin M 2008Clin Immunol2008,129,2:1
12Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy 显示文摘Zhang L Dermawan K Jin M 2008Clin Immunol2008,129,2:1
13Differentialimpairment of regulatory T cells rather than effec-tor T cells by paclitaxel-based chemotherapy 显示文摘Zhang L Dermawan K Jin M 2008Clin Immunol2008,129,2:1
14Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy显示文摘Lei Zhang Kamtai Dermawan Meilin Jin Rongjun Liu Huiru Zheng Lin Xu Yi Zhang Yuchan Cai Yiwei Chu Sidong Xiong 2008Clinical Immunology2008,,:1
15Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy显示文摘ZHANG L DERMAWAN K JIN M 2008C/in Immunol2008,129,2:1
16Differential impairment of regulatory T cells rather than effector T ceils by paclitaxel-based chemotherapy 显示文摘Zhang L Dermawan K Jin M 2008C lin Immunol2008,129,2:1
17Differential impairment of regulatory T cells rather than effeetor T cells by paclitaxel-based chemotherapy显示文摘Zhang L Dermawan K Jin M 2008Clin Immunol2008,129,2:1
18中国-印尼玉米产业科技合作进展及展望显示文摘为了提升印度尼西亚国家玉米产业发展水平,服务国家'一带一路'、'科技服务外交'等国家战略,执行国家科技部对发展中国家科技援助项目,山东省农业科学院玉米研究所开展了印尼本土化玉米育种、新品种与新技术集成和玉米产业科技园区建设等项目内容。利用黄淮海优异种质与印尼富含热带资源种质组配了育种基础材料,育成的10份玉米优异杂交组合正在参加印尼国家玉米品种审定试验;实现了山东省第一次境外农业技术培训班和玉米现场观摩活动,高产栽培技术集成创造了印尼雨季玉米13.70 t/hm^2的高产纪录;建成的50 hm^2中国-印尼玉米产业科技园区,正在为印尼玉米产业的快速发展发挥重要作用。通过科企合作模式,发挥国内农业企业优势,将中国的玉米新品种、新技术引进到印度尼西亚,将会加速印尼玉米产业发展水平,为国家科技外交和'一带一路'战略服务。赵苏娴 王志武 程文 卢增斌 肖焕英 Karlina Syahruddin Rahmansyah Dermawan 丁照华 2020中国农学通报2020,36,27:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费